[Propofol infusion syndrome].
Motsch
J
J
Klinik für Anästhesiologie, Universitätsklinikum Heidelberg. johann.motsch@med.uni-heidelberg.de
Roggenbach
J
J
D000137:Acid-Base Imbalance / Q000139:chemically induced; D000140:Acidosis, Lactic / Q000139:chemically induced*; D000771:Anesthesia, Intravenous; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D002626:Chemistry, Pharmaceutical; D016292:Procedural Sedation; D005227:Fatty Acids / Q000378:metabolism; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects*; D009135:Muscular Diseases / Q000139:chemically induced* / Q000473:pathology; D009336:Necrosis; D010101:Oxygen Consumption / Q000187:drug effects; D015742:Propofol / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013577:Syndrome
D018686:Anesthetics, Intravenous; D005227:Fatty Acids; D006993:Hypnotics and Sedatives; D015742:Propofol
Propofol-Infusionssyndrom.